bYoRNA SAS
keyboard_backspaceBack to Home
Contact
location_on
Pessac
33600 Bordeaux
France
public
Pascal Viguié
CEO
CEO
mail
call
About us
Production of longer, safer and more efficient mRNA by fermentation.
Business offer
mRNA for pre-clinical studies (GLP/ROU).
Activities
- Therapeutic Product
- Genetic Diseases
- Oncology
- Infectiology
- Immunology
- Bioproduction
- Batches production type
- Yeast
- Volume
- Preclinical / Tox
- USP (Scale-Up)
- Cell expansion
- Inoculation
- Low volume containers to Bioreactors
- DSP (Recovery)
- Harvest
- Filtration
- Purification
Categories
Therapeutic applications
Expertises
Directory of Antibodies, Recombinant proteins and others
